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Characteristics of Muscle Fiber Type Are Predictive of Skeletal
Muscle Mass and Strength in Elderly Men
Lex B. Verdijk, PhD, Tim Snijders, MSc, Milou Beelen, MD, Hans H.C.M. Savelberg, PhD,
Kenneth Meijer, PhD, Harm Kuipers, Prof, and Luc J.C. van Loon, PhD
OBJECTIVES: To investigate the relationship between
skeletal muscle fiber type-specific characteristics, circulat-
ing hormone concentrations, and skeletal muscle mass and
strength in older men.
DESIGN: Cross-sectional analyses.
SETTING: University research center.
PARTICIPANTS: Forty-one community dwelling elderly
men (65).
MEASUREMENTS: Leg strength (1-repetition maximum,
1RM) and whole-body and limb muscle mass were deter-
mined, and muscle fiber type composition, cross-sectional
area (CSA), myonuclear content, and satellite cell (SC)
content were assessed in skeletal muscle biopsy samples.
In addition, blood samples were collected to determine
serum testosterone, sex hormone–binding globulin, insu-
linlike growth factor (IGF)-1, and IGF binding protein-3
concentrations.
RESULTS: Muscle mass correlated with muscle strength
(0.41 correlation coefficient (r)0.72; Po.01). Muscle
fiber CSA, myonuclear content, and SC content were sig-
nificantly lower in type II than in type I muscle fibers.
Myonuclear and SC content were positively correlated with
muscle fiber CSA. Furthermore, greater muscle fiber CSA
(type I and II) was associated with greater thigh muscle area
and muscle strength (0.30 r 0.45; Po.05). Testosterone
concentration was positively correlated with muscle mass
and muscle fiber CSA. Regression analysis showed that SC
content, myonuclear content, and testosterone concentra-
tion are predictive of muscle fiber CSA. Furthermore, mus-
cle mass and type II muscle fiber CSA are predictive of
muscle strength.
CONCLUSION: Skeletal muscle mass and strength in
elderly men are positively correlated with muscle fiber
type–specific CSA, myonuclear content, and SC content.
These findings support the assumption that a decline in SC
content plays an important role in age-related decline in
muscle mass and strength. J Am Geriatr Soc 58:2069–2075,
2010.
Key words: sarcopenia; muscle fiber size; satellite cells;
aging; hypertrophy
Aging is associated with the gradual loss of skeletalmuscle mass and function, termed sarcopenia. The
prevalence of sarcopenia is approximately 25% after the
age of 60, increasing to up to approximately 50% in people
aged 80 and older.1–3 The latter is in accordance with the
progressive nature of the loss of muscle mass4–8 and muscle
strength6,9 with aging. The etiology of sarcopenia is gen-
erally studied in a cross-sectional manner within a large
population of individuals ranging in age from 20 to 80,
although few data are available on the determinants of
muscle mass and strength within an elderly population.
Some studies have reported that muscle mass and strength
continue to decline after the age of 65.10,11 This seems
consistent with the greater prevalence of sarcopenia in peo-
ple aged 80 and older than in those aged 60 and older1–3
and agrees with longitudinal changes reported previ-
ously.12,13 Nevertheless, there is a large variability in mus-
cle mass and strength within the elderly population that is
not necessarily related to age per se.14 Therefore, studying
determinants of muscle mass within the elderly population
(independent of age) could provide better insight into the
key etiological factors of sarcopenia.
Leg skeletal muscle mass seems to be the main deter-
minant of leg muscle strength, independent of age.15,16 The
loss of leg muscle mass in older adults has been attributed to
a decline in the number of muscle fibers and, more specifi-
cally, to type II muscle fiber atrophy.8,17,18 These findings
were recently extended by showing a type II muscle fiber–
specific decline in satellite cell (SC) content in older mus-
cle.19 It has been suggested that such a decline in muscle
Address correspondence to Lex Verdijk, Department of Human Movement
Sciences, Faculty of Health, Medicine and Life Sciences, Maastricht Univer-
sity Medical Centre1, P.O. Box 616, 6200 MD Maastricht, the Netherlands.
E-mail: Lex.Verdijk@bw.unimaas.nl
DOI: 10.1111/j.1532-5415.2010.03150.x
From the Department of Human Movement Sciences, NUTRIM School for
Nutrition, Toxicology and Metabolism, Maastricht University Medical
Center, Maastricht, the Netherlands.
JAGS 58:2069–2075, 2010
r 2010, Copyright the Authors
Journal compilation r 2010, The American Geriatrics Society 0002-8614/10/$15.00
fiber SC content plays an important role in muscle fiber
atrophy20,21 and the subsequent loss of muscle mass with
aging. It could be speculated that SC content, muscle fiber
size, and muscle mass are closely linked, independent of
age. Therefore, it was hypothesized that, in an elderly pop-
ulation, muscle fiber size and SC content are correlated and
are predictive of whole-body and limb skeletal muscle mass
and strength.
There have been ample suggestions that age-related
changes in hormonal profile can strongly modulate skeletal
muscle mass and strength in older adults.22 In accordance,
significant correlations have been reported between lean
mass and muscle strength and serum testosterone and
insulinlike growth factor (IGF)-1 concentrations in elderly
men.2,14,23 Furthermore, dose-dependent increases in lean
mass, strength, muscle fiber size, and SC content have been
reported after testosterone supplementation in younger and
older men,24,25 which is indicative of a role for anabolic
hormones in regulating SC-induced muscle fiber hypertro-
phy. The goal of the present study was to extend previous
findings24,25 by investigating the relationship between base-
line serum hormone profiles and muscle characteristics. In
line with potential hormonal regulation of SC, it was hy-
pothesized that baseline hormone concentrations (particu-
larly testosterone) are predictive not only of skeletal muscle
mass and strength, but also of SC content and muscle fiber
size.
The present study aimed to investigate the relationship
between skeletal muscle fiber type-specific characteristics,
circulating hormone concentrations, and skeletal muscle
mass and strength in older men. Skeletal muscle character-
istics were assessed at the whole-body, limb, and muscle
fiber level, and circulating hormone concentrations were
determined in a group of community-dwelling older men.
METHODS
Participants
Forty-one older men (65–86) were included in the present
study. All participants participated in different studies that
are part of a greater project investigating the clinical ben-
efits of exercise and nutritional intervention in older men
for which participants were recruited through advertise-
ments in local newspapers. Medical history of all partici-
pants was evaluated, and an oral glucose tolerance test
(OGTT) and resting electrocardiogram were performed.
Participants with (silent) cardiac or peripheral vascular dis-
ease, orthopedic limitations, or type 2 diabetes mellitus26
were excluded. All participants were living independently
and had no history of participating in any structured ex-
ercise training program for at least 5 years. Furthermore,
participants reported no problems in normal activities of
daily living (e.g., walking, climbing stairs, rising from a
chair) and did not need any assistive equipment (e.g., using
a cane) while walking. Participants taking antihypertensive
medications (n 5 13), cholesterol- or lipid-lowering medi-
cations (n 5 8), medications for prostate or urinary prob-
lems (n 5 8), or no medications (n 5 20) were included in
the study. Individuals with more-severe medical problems
(treatment by medical specialist more than twice a year)
were excluded. Participants from the larger cohort (n 5 59)
were included in the present analysis when a muscle biopsy
was available, with at least 75 type I and 75 type II muscle
fibers being analyzed, which is required to reliably assess
myonuclear and SC content.27 No differences were ob-
served between the participants included in the present
study and the larger cohort regarding age, body composi-
tion, and muscle mass and strength (Table 1). All partici-
pants were informed of the nature and possible risks of the
experimental procedures before written informed consent
was obtained. The Medical Ethics Committee of the
Maastricht University Medical Center approved the study.
Study Design
After inclusion in this study, all participants underwent the
same series of measurements (outlined below) to determine
muscle characteristics at the whole-body, limb, and myo-
cellular level. In addition, a single fasting blood sample was
collected from every participant between 8:00 and 9:00
a.m. to assess hormonal profile. On all test days (muscle
biopsy and blood sampling and dual energy X-ray
absorptiometry (DXA) and computed tomography (CT)
scanning), participants arrived at the laboratory by car or
public transportation at 8:00 a.m. and in an overnight fast-
ing state. In addition, participants were asked to maintain
their normal physical activity pattern in the 3 days before
muscle biopsy collection (no unaccustomed strenuous phys-
ical exercise or labor) to prevent any confounding transient
perturbations in baseline SC content.
Strength Assessment
Maximum strength was assessed according to 1-repetition
maximum (1RM) strength tests on leg press and leg exten-
sion machines (Technogym, Rotterdam, the Netherlands).
During a familiarization trial, proper lifting technique was
demonstrated and practiced. Maximum strength was esti-
mated using the multiple-repetition testing procedure.28 In
an additional session, at least 1 week before muscle biopsy
collection, each participant’s 1RM was determined as de-
scribed previously;29 1RM as determined from the second
session was always the largest value recorded.
Table 1. Subject Characteristics






Age 72  5 (65–86) 72  5 (65–86)
Body mass, kg 80.3  11.8 (63.1–102.2) 79.8  11.1 (63.0–102.2)
Height, m 1.73  0.06 (1.61–1.86) 1.72  0.05 (1.61–1.86)
Body mass index,
kg/m2
27.0  3.5 (21.6–34.6) 26.8  3.2 (21.6–34.6)
Fasting glucose,
mmol/L
5.7  0.6 (4.5–6.9) 5.7  0.6 (4.5–6.9)
Body fat, % 25.4  6.8 (10.6–39.8) 25.3  6.5 (10.6–39.8)
Lean mass, kg 56.1  5.3 (49.0–71.1) 55.9  4.9 (48.8–71.1)
1RM leg extension, kg 84  13 (50–110) 85  12 (50–110)
1RM leg press, kg 170  28 (105–225) 170  27 (105–225)
No differences were observed between the subjects included in the present
study, and the total cohort from which this group was selected.
1RM 5 1-repetition maximum.
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Thigh Muscle Cross-Sectional Area
Anatomical cross-sectional area (CSA) of the thigh muscles
was assessed using CT scanning (IDT 8000, Philips Medical
Systems, the Netherlands), as described previously.30 Scans
were performed at the mid-thigh level, and images were
loaded onto a personal computer using AGFA IMPAX
imaging software, version 5.2 (AGFA Healthcare, Brussels,
Belgium). Muscle area of the right leg was selected between
29 and 1150 Hounsfield units,31 after which the quad-
riceps muscle was selected using manual tracing. Total thigh
and quadriceps muscle area were calculated using Lucia
4.81 software (Nikon Instruments Europe, Badhoevedorp,
the Netherlands). Two investigators blinded to participant
coding performed all analyses; intraclass correlation coeffi-
cients for inter- and intrainvestigator reliability were 0.997
and 0.998, respectively.
Body Composition
Directly after CT scanning, body composition and bone
mineral content were measured using DXA (Lunar Prodigy
Advance, GE Healthcare, Madison, WI). The system’s soft-
ware package (enCORE 2005, version 9.15.00) was used to
determine whole-body and regional lean and fat mass. DXA
scans were performed in a fasting state after participants
had voided. The coefficient of variation (CV) for repetitive
scans (n 5 4, 2 weeks apart) were 0.4%, 1.0%, and 1.1%
for whole-body lean mass, fat mass, and leg lean mass,
respectively. Appendicular skeletal muscle mass (ASM) was
calculated as the sum of lean mass of the arms and legs.1
Body mass was measured to the nearest 0.1 kg using an
electronic balance scale, and height was measured to the
nearest 0.1 cm using a wall-mounted stadiometer. To
control for the potential confounding effect of body size,
all body composition measures were adjusted for knee
height.32 Knee height was chosen instead of full height,
because age-related disorders affecting the spine (e.g.,
osteoporosis) can confound the latter.33
Blood Samples
Blood samples were collected in ethylenediaminetetraacetic
acid–containing tubes and serum tubes. After centrifuga-
tion, aliquots of plasma and serum were frozen in liquid
nitrogen and stored at 801C. Plasma glucose concentra-
tions were analyzed using a COBAS FARA analyzer (Uni
Kit III, Roche, Basel, Switzerland). Total serum testosterone
and sex hormone–binding globulin (SHBG) concentrations
were measured using reagents from Roche Diagnostics
(Mannheim, Germany), and assays were run on a Modular
Analytics E170 analyzer (Hitachi Data Systems, Santa
Clara, CA). The intraassay CVs are 2.7% to 1.8% and
1.1% to 1.7% for low to high concentrations of testoster-
one and SHBG, respectively. Bioavailable testosterone was
calculated as non-SHBG-bound testosterone using a for-
mula described and validated previously.34 IGF-1 was an-
alyzed on a Liaison system (DiaSorin, Brussels, Belgium)
with reagents from DiaSorin. Intraassay CVs are 2.4% to
4.4% for high and low concentrations, respectively. IGF
binding protein (BP)-3 was analyzed using a commercially
available test kit (Biosource Europe, Nivelles, Belgium) on a
Tecan/GENios analyzer (Tecan Group Ltd., Männedorf,
Switzerland), with intraassay CVs of 4% to 8%.
Muscle Biopsy Sampling
Muscle biopsy samples were collected from the right leg in
the morning after an overnight fast. After local anesthesia,
percutaneous needle biopsies (50–80 mg) were taken from
the vastus lateralis muscle, approximately 15 cm above the
patella.35 Any visible nonmuscle tissue was removed
immediately, and biopsy samples were embedded in
Tissue-Tek (Sakura Finetek, Zoeterwoude, the Nether-
lands), frozen in liquid nitrogen–cooled isopentane, and
stored at 801C.
Immunohistochemistry
From all biopsies, 5-mm-thick cryosections were cut at
 201C. Samples from two participants were mounted to-
gether on uncoated glass slides. Care was taken to align the
samples properly for cross-sectional fiber analyses. Serial
cross-sections were stained for muscle fiber typing and
myocellular SC content. Details of the analytical procedures
have been described previously.30 In short, muscle fiber
typing (type I vs II) was determined based on myosin heavy
chain staining, and a CD56 antibody was used to determine
SC content. Laminin was used to visualize the basement
membrane, and nuclei were stained with 40,6-diamidino-
2-phenylindole (DAPI). After staining, all images were
digitally captured using fluorescence microscopy (Nikon
Instruments Europe). Image processing and quantitative
analyses were done using the Lucia 4.81 software package.
An investigator blinded to participant coding performed all
image recordings and analyses. Within each image, the
number of fibers, the mean fiber CSA, the number of myo-
nuclei per fiber, and the myonuclear domain (fiber CSA/
number of myonuclei) were measured for the type I and
type II muscle fibers separately. For the SC slides, fiber typ-
ing was determined by matching the serial fiber typing
slides. SCs were determined at the periphery of each fiber
and stained positive for deoxyribonucleic acid (DAPI) and
CD56. The number of SCs per muscle fiber and the per-
centage of SC [number of SCs/(number of SC1number of
myonuclei)  100] were determined for the type I and II
muscle fibers separately. A mean total of 338  152 muscle
fibers (178  90 type I and 160  77 type II muscle fibers)
were analyzed for each participant. To determine interob-
server reliability for the number of SCs per fiber, two in-
vestigators blinded to participant coding analyzed five
randomly chosen biopsy specimens; the CV was 1.5%.
Furthermore, the agreement in determination of the fiber
type to which SCs belong was shown to be 99%.
Statistics
Sample size was calculated based on previous findings;9,36
20 to 39 participants were needed to detect significant
correlations between muscle fiber CSA, muscle mass,
and muscle strength (with power 5 0.80 and a5 0.05).
Kolmogorov-Smirnov tests showed that age was the only
variable that was not normally distributed. To determine
the relationship between age and all other variables (mea-
sured using DXA, CT, muscle biopsy, and blood sample
analyses), Spearman rank correlation coefficients (r) were
calculated. The relationship between the various muscle
characteristics and between muscle characteristics and hor-
monal profiles were determined by calculating bivariate
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Pearson correlation coefficients. In addition, partial corre-
lations (adjusting for the effect of age) were calculated,
eliminating age as a contributing factor to the correlation.
Likewise, the correlation between age and muscle strength
was adjusted for the effect of quadriceps CSA. Differences
between the various correlation coefficients were tested for
statistical significance.37 Differences between type I and II
muscle fibers were analyzed using paired-samples t-tests.
Forward linear regression modeling was used to identify the
main predictors for muscle mass and strength (quadriceps
and thigh CSA, and 1RM leg press and leg extension) and
muscle fiber size. Based on the results of the correlation
analysis, a number of independent variables were included
as potential predictors. Because age was not normally dis-
tributed, this variable was fit as a categorical variable (o70,
70–74, and 75). All analyses were performed using SPSS
version 15.0 (SPSS, Inc., Chicago, IL). An a-level of .05 was
used to determine statistical significance. Differences be-
tween type I and II muscle fibers were determined using
two-sided tests. Correlation coefficients were determined
using one-sided tests because specific directions were ex-
pected for the correlations studied. All data are presented as
means  standard deviations.
RESULTS
Participant characteristics are provided in Table 1. The
mean age of the participants was 72  5 (range 65–86).
Basal blood glucose concentrations, glycosylated hemoglo-
bin levels, and oral glucose tolerance were within the nor-
mal range for healthy older men.
Age-Related Changes
Age did not correlate with whole-body lean mass, although
there was a significant negative correlation between age and
regional measures of muscle mass, with the strongest cor-
relations observed between age and total thigh and quad-
riceps muscle CSA (Table 2). In addition, for the leg press
and leg extension exercises, muscle strength was negatively
correlated with age (r 5  0.38 and  0.37, P 5.008 and
.009, respectively). When adjusted for the effect of quad-
riceps muscle CSA, the correlation between age and muscle
strength disappeared (leg press: r 5  0.10, P 5.52, leg
extension: r 5  0.14 P 5.41).
At the myocellular level, type II muscle fiber CSA was
shown to be smaller than type I muscle fiber CSA (Table 3).
In addition, myonuclear and SC content were lower in the
type II than the type I muscle fibers. Whereas the percentage
of type I and II muscle fiber was similar, the percentage of
type II muscle fiber area was smaller than of type I muscle
fiber area. In contrast to type I muscle fiber CSA, type II
muscle fiber CSA correlated significantly with age
(r 5  0.23; P 5.04).
Whole-Body, Regional, and Myocellular Characteristics
All measures of lean mass (whole-body and regional lean
mass) and thigh and quadriceps CSA showed positive cor-
relations with each other and with leg extension and leg
press strength (Table 2). Correlations between quadriceps
CSA and leg extension strength (r 5 0.72) and between
thigh CSA and leg press strength (r 5 0.72) were most pro-
nounced (Po.001). Partial correlation coefficients showed
that the relationships between muscle mass and strength did
not change when adjusted for age.
For the type I and II muscle fibers, greater muscle
fiber CSA was associated with more myonuclei per fiber, a
greater myonuclear domain, and more SCs per muscle fiber
(Table 4). In addition, the number of myonuclei per muscle
fiber correlated positively with the number of SCs per mus-
cle fiber (r 5 0.40 for type I and II muscle fibers; P 5.006).
Type I and II muscle fiber CSA showed a positive cor-
relation with leg extension strength (Figure 1) but not with
leg press strength. Furthermore, greater muscle fiber CSA
Table 2. Characteristics of Lean Body Mass and Their Correlations with Age and Muscle Strength
Characteristic Mean  SD
r Age,
Mean  SEE P-Value
r 1RM-LE,
Mean  SEE P-Value
r 1RM-LP,
Mean  SEE P-Value
Whole-body lean mass, kg 56.1  5.3  0.24  0.16 .07 0.41  0.15 .005 0.48  0.14 .001
Leg lean mass, kg 17.8  1.9  0.36  0.15 .01 0.44  0.14 .002 0.55  0.13 o.001
Arm lean mass, kg 6.5  0.8  0.26  0.16 .05 0.54  0.13 o.001 0.45  0.14 .002
Appendicular skeletal muscle mass, kg 24.3  2.5  0.36  0.15 .01 0.51  0.14 o.001 0.57  0.13 o.001
Quadriceps muscle CSA, cm2 73.0  11.3  0.50  0.13 o.001 0.72  0.11 o.001 0.67  0.12 o.001
Thigh CSA, cm2 159.2  19.2  0.52  0.13 o.001 0.67  0.12 o.001 0.72  0.11 o.001
Spearman rank (for age) and Pearson (for one-repetition maximum (1RM) for leg extension (LE) and leg press (LP)) correlation coefficients (r).
 Sum of lean mass in arms and legs.
SEE 5 standard error of the estimate; CSA 5 cross-sectional area.
Table 3. Muscle Fiber Type Characteristics
Mean  Standard Deviation
Characteristic Type I Type II
Fiber, % 52  13 48  13
CSA, mm2 6,460  1,662 5,276  1,402
CSA% 57  14 43  14
Nuclei/fiber 3.3  0.8 2.7  0.7
Nuclear domain, mm2 2,036  75 1,970  79
SCs/fiber 0.087  0.031 0.050  0.016
SC% 2.7  0.9 1.8  0.6
 Significantly different from type I muscle fibers.
CSA 5 cross-sectional area; CSA% 5 percentage of total area occupied per
fiber type; SC 5 satellite cell; SC% 5 percentage of SCs (number of SCs/
(number of SCs1number of myonuclei)  100%).
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was associated with greater quadriceps CSA and greater
thigh CSA (Table 4). Adjusting for age did not modulate any
of the correlations.
Hormonal Profiles and Muscle Characteristics
Average serum concentrations of total testosterone,
bioavailable testosterone, SHBG, IGF-I, and IGF-BP3 were
16.1  4.8 nmol/L, 5.8  1.6 nmol/L, 52.3  12.7 nmol/L,
15.1  4.8 nmol/L, and 76.1  11.8 nmol/L, respectively.
Higher total testosterone concentrations were associated
with higher serum SHBG concentrations (r 5 0.52,
Po.001). Bioavailable testosterone concentrations corre-
lated positively with IGF-1 (r 5 0.31, P 5.02). In addition,
a positive correlation was observed between IGF-1 and
IGF-BP3 (r 5 0.46, P 5.001).
Higher levels of bioavailable testosterone were associ-
ated with greater ASM (r 5 0.26; P 5.04) and greater mus-
cle mass measured using CT (r 5 0.27; P 5.04). Whereas
type II muscle fiber CSA was greater with higher concentra-
tions of bioavailable testosterone expressed as a percentage
of total testosterone (r 5 0.30; P 5.03), this correlation was
not significant for type I muscle fibers (r 5 0.23; P 5.07).
Furthermore, higher bioavailable testosterone levels were
associated with a larger percentage of fiber area occupied by
type II muscle fibers (r 5 0.31; P 5.02). No positive corre-
lations were observed for type I and II muscle fiber myo-
nuclear or SC content with any of the hormones measured.
Linear Regression Analysis
Based on the outcome of the correlation analysis, potential
predictors of muscle mass and strength were analyzed in a
regression model. For muscle strength, the independent
variables were age, quadriceps and thigh CSA, bioavailable
testosterone concentration, and type I and II muscle fiber
CSA. For muscle mass, the independent variables were age,
bioavailable testosterone concentration, and type I and II
muscle fiber CSA. For muscle fiber type I and II CSA, the
independent variables were age, bioavailable testosterone
concentration, and myonuclear and SC content (type I and
II, respectively).
Total thigh CSA alone was shown to predict 1RM leg
press (coefficient of determination (R2) 5 0.52), and quad-
riceps CSA and type II muscle fiber CSA predicted 1RM leg
extension (R2 5 0.54). Age and type II muscle fiber CSA
significantly predicted total thigh (R2 5 0.28) and quadri-
ceps CSA (R2 5 0.32). Finally, the number of myonuclei per
fiber, the number of SCs per fiber, and bioavailable testos-
terone concentration significantly predicted type I (R2 5
0.49) and type II (R2 5 0.48) muscle fiber CSA.
DISCUSSION
The present study shows that muscle fiber type character-
istics, bioavailable testosterone concentration, and muscle
mass are closely correlated, providing important predictors
of skeletal muscle mass and strength in older men. The
findings indicate that SC content and muscle fiber CSA are
tightly coupled, concurrent with the assumption that a de-
cline in SC content plays an important role in type II muscle
fiber specific atrophy and, as such, in the loss of skeletal
muscle mass and strength in older men.
The present study shows that skeletal muscle mass
correlates strongly with muscle strength in older men.
Although longitudinal changes were not studied, this find-
ing supports the concept that the loss of muscle mass is
associated with muscle weakness, resulting in functional
impairment in older adults.16,38 Previous studies with
participants selected over a wide age range (18–80) re-
ported significant correlations between strength and muscle
fiber size.9,36 The current study extends these findings by
showing that, independent of age, smaller type I and II
muscle fiber size is associated with a smaller quadriceps
CSA and lower leg strength in an older male population.
The correlation between muscle fiber size and muscle
strength tended to be stronger for type II than type I muscle
fibers (Figure 1). Although speculative, this might be partly
attributed to the observation that type II muscle fibers can
generate greater specific tension, explaining their impor-
tance for explosive force production.39 As such, specific
type II muscle fiber atrophy with aging contributes to the
development of muscle weakness from a quantitative (loss
Table 4. Correlations Between Skeletal Muscle Charac-
teristics and Muscle Fiber Cross-Sectional Area (CSA)
Pearson Correlation
Coefficient  Standard Error of the
Estimate, P-Value
Characteristic Type I CSA Type II CSA
Nuclei/fiber 0.56  0.13, o.001 0.56  0.13, o.001
Nuclear domain 0.41  0.15, .005 0.50  0.14, .001
Satellite cells/fiber 0.55  0.13, o.001 0.50  0.14, o.001
Quadriceps muscle CSA 0.33  0.15, .02 0.39  0.15, .006
Thigh CSA 0.30  0.15, .03 0.39  0.15, .006
One-repetition maximum
Leg extension 0.32  0.15, .02 0.45  0.14, .002
Leg press 0.07  0.16, .33 0.14  0.16, .19
Figure 1. Scatter plot for the correlation of type I (filled circles)
and type II (open circles) muscle fiber cross-sectional area (CSA)
with one-repetition maximum (1RM) leg extension strength.
Lines represent the fitted regression. Pearson correlation coeffi-
cients (r) tended to be stronger (P 5.06) for type II (dashed line,
r 5 0.45, P 5.002) than type I muscle fibers (solid line, r 5 0.33,
P 5.02).
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of muscle fiber area) and a qualitative (relative increase in
type I muscle fiber area) perspective. The finding that quad-
riceps muscle fiber size was significantly correlated with leg
extension but not leg press strength (Table 4) is probably
related to the fact that leg extension represents isolated
quadriceps and knee extension strength, whereas leg press
represents combined hip, knee, and ankle extension
strength.29 As such, other factors, such as the ability to
coordinate force production in different muscles and joints,
may have obscured the potential correlation between mus-
cle fiber size and leg press strength.
The correlation between age and muscle strength dis-
appeared when corrected for muscle CSA. In accordance,
regression analysis showed that muscle mass and type II
muscle fiber size are the main predictors of muscle strength
(explaining 450% of the variance). In general, muscle
mass and quality determine muscle strength. Because age
was not shown to contribute significantly to the variability
in strength, it seems that age does not affect muscle quality
per se. Other factors, such as type II muscle fiber atrophy,
greater intramuscular lipid or connective tissue con-
tent,40,41 impaired neural function,4 and a lower physical
activity level4,14 have been associated with poorer muscle
quality and, as such, lower muscle strength. Because these
aspects were not specifically addressed in the present study,
their relative importance for muscle strength remains to be
determined.
Type II muscle fiber CSA was shown to be smaller than
type I muscle fiber CSA (Table 3). In addition, myonuclear
and SC content were lower in type II than type I muscle
fibers, which is consistent with previous findings.8,17,19,30,42
Type I and type II muscle fiber SC and myonuclear content
were positively correlated with muscle fiber CSA, consistent
with the myonuclear domain theory.43–45 It has been pro-
posed that changes in SC content play an important role in
age-related skeletal muscle atrophy19–21,46–48 and exercise-
induced muscle hypertrophy.30,43 Therefore, it was specu-
lated that skeletal muscle SC content acts as an important
regulator of muscle fiber size, as the outcome of the regres-
sion analysis supports, showing that SC and myonuclear
content can be predictive of muscle fiber size. As such, the
muscle fiber type–specific decline in SC content observed
with aging seems to represent an important factor in the
age-related loss of muscle mass and strength.
Consistent with previous findings,2,23 a positive corre-
lation was found between bioavailable testosterone levels
and muscle mass (CT, DXA) and muscle fiber size. Together
with SC and myonuclear content, bioavailable testosterone
was also shown to be predictive of muscle fiber size, al-
though despite previous findings,25 no correlation was seen
between testosterone and myonuclear or SC content. Al-
though this might imply that the primary action of testos-
terone is not directed toward SCs, more research is
warranted to address this question. Is has been suggested
that local and systemic IGF-1 play a role in regulating the
SC cycle,20,49 although no correlations were observed be-
tween IGF-1 concentrations and SC content. Moreover, in
contrast to previous studies,14,23 no correlations were ob-
served between IGF-1 and various measures of muscle
mass. The small variability in IGF-1 and muscle mass in the
participant population included in the present study might
explain these findings. Alternatively, it might be that
muscle-specific IGF-1 is a stronger predictor of muscle
mass and myogenic potential, and future research should
further delineate the specific roles of muscle-specific and
systemic IGF-1 in regulating skeletal muscle mass.49
The present cross-sectional analysis does not allow any
direct causal relationships to be determined. Age-related
changes in muscle characteristics (e.g., muscle fiber
atrophy) generally represent slowly progressing processes,
taking 20 to 30 years to become apparent.8 As such,
longitudinal studies are difficult to assess because of meth-
odological problems regarding follow-up duration and high
dropout rates. In the present study, whether the known age-
related changes in muscle fiber characteristics can explain
the large variance in muscle mass and strength in a pop-
ulation of community-dwelling elderly men was therefore
assessed. This is the first study to show predictive associ-
ations between SC content, muscle fiber size, and skeletal
muscle mass and strength in elderly men.
The sample size of the present study and the inclusion
of only relatively healthy elderly men may limit its potential
for generalization to other subpopulations such as women
or frail older men. Nonetheless, combined with the findings
from recent intervention studies25,30 and in vivo animal
experiments,21,43,46 the current data indicate that SCs play
an important role in the age-related loss of muscle mass and
function.
In conclusion, muscle mass and muscle fiber size are
predictive of skeletal muscle strength in elderly men. Fur-
thermore, SC content, myonuclear content, and bioavail-
able testosterone concentration seem to play important
roles in regulating muscle fiber size and, as such, skeletal
muscle mass and strength in older men. These findings pro-
vide further support to the idea that a decline in type II
muscle fiber SC content plays an important role in the loss
of muscle mass and strength with aging.
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